N
Naoto T. Ueno
Researcher at University of Texas MD Anderson Cancer Center
Publications - 390
Citations - 13778
Naoto T. Ueno is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Breast cancer & Inflammatory breast cancer. The author has an hindex of 59, co-authored 389 publications receiving 11623 citations. Previous affiliations of Naoto T. Ueno include University of Texas Health Science Center at Houston & The Breast Cancer Research Foundation.
Papers
More filters
Journal ArticleDOI
Guided Self-Help for Prevention of Depression and Anxiety in Women with Breast Cancer
Hiroko Komatsu,Naoko Hayashi,Kumi Suzuki,Kaori Yagasaki,Yukiko Iioka,Joyce L. Neumann,Seigo Nakamura,Naoto T. Ueno +7 more
TL;DR: An oncology nurse-guided self-help kit with a cognitive behavioral therapy approach to 46 women with breast cancer in the intervention group and usual care to 36 in the control group in outpatient chemotherapy settings, with no significant differences between the two groups.
Journal ArticleDOI
Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis
Yosuke Watanabe,Fumiyuki Yamasaki,Yoshinori Kajiwara,Taiichi Saito,Takeshi Nishimoto,Chandra Bartholomeusz,Naoto T. Ueno,Kazuhiko Sugiyama,Kaoru Kurisu +8 more
TL;DR: High PEA-15 expression level was inversely associated with WHO grade and may serve as an important prognostic factor for high-grade astrocytomas.
Journal ArticleDOI
Information Sharing and Case Conference Among the Multidisciplinary Team Improve Patients’ Perceptions of Care
Hiroko Komatsu,Kazuhiro Nakayama,Taisuke Togari,Kumi Suzuki,Naoko Hayashi,Yoshie Murakami,Yukiko Iioka,Wakako Osaka,Kaori Yagasaki,Seigo Nakamura,Joyce Neumann,Naoto T. Ueno +11 more
TL;DR: Integrated patient-based information and regular multidisciplinary case conferences that include records of viewpoints from different professionals improve patients’ perceptions of comprehensive breast cancer care.
Journal ArticleDOI
Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer
Jangsoon Lee,Rachael Galloway,Geoff Grandjean,Justin Jacob,Juliane Humphries,Chandra Bartholomeusz,Samantha Goodstal,Bora Lim,Geoffrey Bartholomeusz,Naoto T. Ueno,Arvind Rao +10 more
TL;DR: A novel powerful high-throughput RNAi assays were able to identify anti-cancer drugs as single or combinational agents and revealed the PI3K pathway as the major target pathway in RNAi combination studies in TNBC.
Journal ArticleDOI
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research
Jose Rodrigo Espinosa Fernandez,Bedrich L. Eckhardt,Jangsoon Lee,Bora Lim,Troy Pearson,Rob S. Seitz,David R. Hout,Brock L. Schweitzer,Tyler J. Nielsen,O. Rayne Lawrence,Ying Wang,Arvind Rao,Naoto T. Ueno +12 more
TL;DR: Six TNBC cell lines with concordant molecular subtypes maintained their subtype classification between in vitro and tumor xenograft analyses across both algorithms and are recommended for TNBC molecular classification–guided translational research.